Anbio Biotechnology (NASDAQ:NNNN) Shares Up 5.3% – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s share price shot up 5.3% during trading on Friday . The stock traded as high as $25.99 and last traded at $26.3950. 2,602 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 45,977 shares. The stock had previously closed at $25.07.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, April 1st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Anbio Biotechnology Price Performance

The firm’s 50 day moving average is $25.26.

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 earnings per share for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.